Article Text

PDF
Metabolic syndrome and chronic hepatitis B: is the evidence enough?
  1. Henry Lik-Yuen Chan,
  2. Grace Lai-Hung Wong,
  3. Vincent Wai-Sun Wong
  1. Institute of Digestive Disease and Department of Medicine and Therapeutics, The Chinese University of Hong Kong; Hong Kong SAR, China
  1. Correspondence to Dr Henry Lik-Yuen Chan, Department of Medicine and Therapeutics, 9/F Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong, China; hlychan{at}cuhk.edu.hk

Statistics from Altmetric.com

We appreciated the interest and comment of Li and colleagues on our recent publication.1 We would like to acknowledge the results from the Taiwanese longitudinal studies concerning the effect of fatty liver, obesity and type 2 diabetes on the risk of liver cirrhosis and hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients. This evidence echoed the conclusion of the present study that metabolic syndrome increased the risk of liver cirrhosis in CHB.

In the present cross-sectional study, the causal …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles